ResultsMoneycontrol
Suraksha Diagnostics Q2 FY27: High-performing stock trading at a discount
Positive+66
GreyOak summary
Suraksha Diagnostics reported strong margins and profitable new centers in Q2 FY27. The company is expanding into high-value diagnostics, strengthening its growth outlook. The stock is currently trading at a discount.
What it affects
- HealthcarePositive +66
Diagnostics sector shows strong growth outlook.Rolling sentiment Positive +37